Literature DB >> 3677416

Bile acid metabolism in cirrhotic liver tissue--altered synthesis and impaired hepatic secretion.

Y Akashi1, H Miyazaki, J Yanagisawa, F Nakayama.   

Abstract

Bile acid analysis of mild and severe cirrhotic liver showed that with the advancement of cirrhosis the concentration of chenodeoxycholic acid in liver tissue becomes higher, resulting in the lower ratio of cholic to chenodeoxycholic acid probably due to the progressive alteration of cholic and chenodeoxycholic acid synthesis with the advancement of liver cirrhosis. Bile acid analysis of paired liver and bile of severe cirrhosis showed that the ratio of cholic to chenodeoxycholic acid in liver was lower than that in bile or even with that in bile. This can be explained by postulating the impaired hepatic secretion of bile acids, especially chenodeoxycholic acid. The impaired secretion together with the relatively well preserved chenodeoxycholic acid synthesis results in the accumulation of chenodeoxycholic acid in liver tissue with cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3677416     DOI: 10.1016/0009-8981(87)90289-0

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  6 in total

1.  Engineered three-dimensional liver mimics recapitulate critical rat-specific bile acid pathways.

Authors:  Christopher J Detzel; Yeonhee Kim; Padmavathy Rajagopalan
Journal:  Tissue Eng Part A       Date:  2010-12-19       Impact factor: 3.845

2.  Ursodeoxycholic acid therapy in chronic active hepatitis.

Authors:  M C Bateson
Journal:  Postgrad Med J       Date:  1990-09       Impact factor: 2.401

3.  Evaluation of gallbladder motility in patients with liver cirrhosis: relationship to gallstone formation.

Authors:  C P Li; S J Hwang; F Y Lee; F Y Chang; H C Lin; R H Lu; C J Chu; S D Lee
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.199

Review 4.  Clinical pharmacokinetics of therapeutic bile acids.

Authors:  A Crosignani; K D Setchell; P Invernizzi; A Larghi; C M Rodrigues; M Podda
Journal:  Clin Pharmacokinet       Date:  1996-05       Impact factor: 6.447

5.  Ursodeoxycholic acid administration on bile acid metabolism in patients with early stages of primary biliary cirrhosis.

Authors:  G Mazzella; P Parini; F Bazzoli; N Villanova; D Festi; R Aldini; A Roda; A Cipolla; C Polimeni; D Tonelli
Journal:  Dig Dis Sci       Date:  1993-05       Impact factor: 3.199

6.  Alterations of bile acid composition in gallstones, bile, and liver of patients with hepatolithiasis, and their etiological significance.

Authors:  J Shoda; N Tanaka; B F He; Y Matsuzaki; T Osuga; H Miyazaki
Journal:  Dig Dis Sci       Date:  1993-11       Impact factor: 3.199

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.